← Leaderboards
David Cardy Lafon
University Of Alabama At Birmingham
$864,878
Attributed
$864,878
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $384.3K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$864,878 · 2
By mechanism
K08$642,128 · 1
R03$222,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert P Kimberly$63,455,986
- David E Briles$11,417,266
- Jianming Wu$2,383,359
- Clinton J. Grubbs$3,836,849
- Elaine Tuomanen$16,379,473
Others in their field
Other Rising Stars on “Impairment”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- James Cappo · National Jewish Health$9,298,220
- Robert C Alexander · Banner Health$8,197,111
Research focus
ImpairmentPersonalized MedicineIgg2Immunoglobulin GMortalityPathway InteractionsGenetic VariantHealth Care CostsImmune FunctionImmune System DiseasesMorbidity - Disease RateBacteriaNovel StrategiesParticipantCohort StudiesFollow-UpAllelesChronic Obstructive Pulmonary DiseaseCohortImmuneAntibodiesImmune ResponseInvestigationPredisposition
Grant awards (5)
Immunogenetic risk factors for exacerbations in African American people with COPD$222,750
R03 · FY2025 · HL · contact PI
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease$161,585
K08 · FY2025 · HL · contact PI
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease$161,261
K08 · FY2024 · HL · contact PI
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease$159,641
K08 · FY2023 · HL · contact PI
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease$159,641
K08 · FY2022 · HL · contact PI